-
Vaccine group says 5 million-plus lives can be saved over next few years in poor countries
GAVI Alliance believes its five-year plan to vaccinate another 300 million children worldwide will save at least 5 million lives. It will also save billions of dollars now lost to treatment of the preventable illnesses and other costs, like parents' lost wages, members of the alliance said.
- Categories
- Health Care
-
Defying stigma, survivors join the Ebola fight in West Africa
The worst outbreak of Ebola on record has killed 5,000 people in West Africa, mostly in Guinea and neighbouring Liberia and Sierra Leone. But thousands more have survived, ostracised by fearful communities ravaged by the disease.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Weekly Roundup – 10/25/14: Why Ebola could spell collaboration for drugmakers and even adversarial countries
Amid all the finger-wagging about Ebola, two pharmaceutical giants have decided to collaborate to find a cure. What else could happen if we look at infectious diseases through a different prism?
- Categories
- Health Care
-
Drugmakers to join forces to make millions of Ebola vaccine doses
Leading drugmakers plan to work together to accelerate development of an Ebola vaccine and produce millions of doses of the most effective experimental product for use next year.
- Categories
- Health Care
-
Pharma companies feel law change can weaken ability to provide low-cost drugs
Indian drugmakers and public health activists are deeply worried that sections of the American pharmaceutical industry may use the recently announced Indo-US working committee on intellectual property rights to force changes in Indian patent laws to further their commercial interests at the cost of the domestic industry.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
OPINION: Ebola: The dark side of globalization
As upcoming goals, the United Nations should enact basic sanitation, healthcare and governance in failed or collapsing states not simply because of moral concerns, but because of our own safety concerns.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Issues continue to dog the testing of Ebola drugs and vaccines
The fact that no “flexible and innovative protocol” exists for Ebola speaks to the complex practical and ethical issues that surround the use of untested drugs and vaccines in the midst of the explosive spread of a virus that kills more than half the people it infects.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Profit motive big hurdle for Ebola drugs, experts say
For nearly four decades, mention of the Ebola virus has evoked death and terror, yet a simple factor—money—has stood in the way of erasing the curse, experts say.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.